A closed-loop drug-delivery system could improve chemotherapy

New CLAUDIA system could continuously monitor patients during an infusion and adjust dosage to maintain optimal drug levels.

Anne Trafton | MIT News • mit
yesterday ~9 min

A biomedical engineer pivots from human movement to women’s health

Postdoc Shaniel Bowen studies women's sexual anatomy and health while also working to interest young women in STEM careers.

Michaela Jarvis | School of Engineering • mit
April 12, 2024 ~7 min


When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria

Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.

Alex Ouyang | Abdul Latif Jameel Clinic for Machine Learning in Health • mit
April 8, 2024 ~4 min

A protein found in human sweat may protect against Lyme disease

Researchers also found that a variant of the protein is not as protective against the bacteria and increases susceptibility to the disease.

Anne Trafton | MIT News • mit
March 19, 2024 ~8 min

A sprayable gel could make minimally invasive surgeries simpler and safer

Applied during endoscopic procedures, GastroShield could help prevent complications such as bleeding and leakage from weakened gastrointestinal tissues.

Anne Trafton | MIT News • mit
March 12, 2024 ~7 min

Deciphering the cellular mechanisms behind ALS

Professor Ernest Fraenkel has decoded fundamental aspects of Huntington’s disease and glioblastoma, and is now using computation to better understand amyotrophic lateral sclerosis.

Michaela Jarvis | School of Engineering • mit
March 6, 2024 ~8 min

A noninvasive treatment for “chemo brain”

Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.

Anne Trafton | MIT News • mit
March 6, 2024 ~7 min

New model identifies drugs that shouldn’t be taken together

Using a machine-learning algorithm, researchers can predict interactions that could interfere with a drug’s effectiveness.

Anne Trafton | MIT News • mit
Feb. 20, 2024 ~6 min


Hitchhiking cancer vaccine makes progress in the clinic

MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.

Bendta Schroeder | Koch Institute • mit
Feb. 15, 2024 ~11 min

Scientists develop a low-cost device to make cell therapy safer

A plastic microfluidic chip can remove some risky cells that could potentially become tumors before they are implanted in a patient.

Adam Zewe | MIT News • mit
Feb. 7, 2024 ~8 min

/

49